Statements (52)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:protein
|
gptkbp:administeredBy |
injection
|
gptkbp:approvedBy |
gptkb:FDA
|
gptkbp:category |
cytokine
|
gptkbp:discoveredBy |
gptkb:Jean_Lindenmann
gptkb:Alick_Isaacs |
gptkbp:discoveredIn |
1957
|
gptkbp:encodedBy |
IFN genes
|
gptkbp:example |
gptkb:interferon_gamma
gptkb:interferon_beta interferon alpha interferon lambda |
gptkbp:foundIn |
vertebrates
|
gptkbp:function |
immunomodulation
antiviral response inhibition of cell proliferation |
gptkbp:halfLife |
several hours
|
https://www.w3.org/2000/01/rdf-schema#label |
Interferons
|
gptkbp:inducedBy |
expression of interferon-stimulated genes
|
gptkbp:inhibitedBy |
viral replication
tumor cell growth |
gptkbp:mechanismOfAction |
activation of immune cells
induction of antiviral proteins upregulation of MHC molecules |
gptkbp:molecularWeight |
17-25 kDa
|
gptkbp:producedBy |
gptkb:leukocytes
gptkb:natural_killer_cells gptkb:T_cells fibroblasts epithelial cells |
gptkbp:promotion |
antigen presentation
macrophage activation natural killer cell activity |
gptkbp:recipient |
gptkb:interferon_alpha/beta_receptor
interferon gamma receptor interferon lambda receptor |
gptkbp:regulates |
immune response
|
gptkbp:sideEffect |
gptkb:depression
gptkb:anemia fatigue flu-like symptoms |
gptkbp:structure |
gptkb:protein
|
gptkbp:type |
Type I interferon
Type II interferon Type III interferon |
gptkbp:usedFor |
treatment of hepatitis C
treatment of multiple sclerosis treatment of hepatitis B treatment of some cancers |
gptkbp:bfsParent |
gptkb:L03AB08
gptkb:L03AB13 |
gptkbp:bfsLayer |
7
|